3 assets in Cellular Phase Chronic Idiopathic Myelofibrosis

Therapeutic assets addressing Cellular Phase Chronic Idiopathic Myelofibrosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Azacitidine Cellular Phase Chronic Idiopathic Myelofibrosis	M.D. Anderson Cancer Center	P1/2	CCC (48)
Pevonedistat Cellular Phase Chronic Idiopathic Myelofibrosis	M.D. Anderson Cancer Center	P1/2	CCC (48)
Venetoclax Cellular Phase Chronic Idiopathic Myelofibrosis	M.D. Anderson Cancer Center	P1/2	CCC (48)